441 related articles for article (PubMed ID: 30350771)
21. Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.
Kim S; Nguon C; Guillard B; Duong S; Chy S; Sum S; Nhem S; Bouchier C; Tichit M; Christophel E; Taylor WR; Baird JK; Menard D
PLoS One; 2011; 6(12):e28357. PubMed ID: 22164279
[TBL] [Abstract][Full Text] [Related]
22. Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
Ley B; Winasti Satyagraha A; Rahmat H; von Fricken ME; Douglas NM; Pfeffer DA; Espino F; von Seidlein L; Henriques G; Oo NN; Menard D; Parikh S; Bancone G; Karahalios A; Price RN
PLoS Med; 2019 Dec; 16(12):e1002992. PubMed ID: 31834890
[TBL] [Abstract][Full Text] [Related]
23. Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia.
Adhikari B; Tripura R; Dysoley L; Callery JJ; Peto TJ; Heng C; Vanda T; Simvieng O; Cassidy-Seyoum S; Ley B; Thriemer K; Dondorp AM; von Seidlein L
Malar J; 2022 Oct; 21(1):282. PubMed ID: 36195916
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia.
Wojnarski B; Lon C; Sea D; Sok S; Sriwichai S; Chann S; Hom S; Boonchan T; Ly S; Sok C; Nou S; Oung P; Kong N; Pheap V; Thay K; Dao V; Kuntawunginn W; Feldman M; Gosi P; Buathong N; Ittiverakul M; Uthaimongkol N; Huy R; Spring M; Lek D; Smith P; Fukuda MM; Wojnarski M
PLoS One; 2020; 15(1):e0228207. PubMed ID: 32004348
[TBL] [Abstract][Full Text] [Related]
25. Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency.
LaRue N; Kahn M; Murray M; Leader BT; Bansil P; McGray S; Kalnoky M; Zhang H; Huang H; Jiang H; Domingo GJ
Am J Trop Med Hyg; 2014 Oct; 91(4):854-861. PubMed ID: 25071003
[TBL] [Abstract][Full Text] [Related]
26. Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.
Recht J; Ashley EA; White NJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006230. PubMed ID: 29672516
[TBL] [Abstract][Full Text] [Related]
27. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
Watson J; Taylor WRJ; Bancone G; Chu CS; Jittamala P; White NJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199
[TBL] [Abstract][Full Text] [Related]
28. First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea.
Goo YK; Ji SY; Shin HI; Moon JH; Cho SH; Lee WJ; Kim JY
PLoS One; 2014; 9(5):e97390. PubMed ID: 24853873
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness analysis of G6PD diagnostic test for Plasmodium vivax radical cure in Lao PDR: An economic modelling study.
Aung YN; Tun STT; Vanisaveth V; Chindavongsa K; Kanya L
PLoS One; 2022; 17(4):e0267193. PubMed ID: 35468145
[TBL] [Abstract][Full Text] [Related]
30. Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis.
Brito M; Rufatto R; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Menezes A; Ataídes R; Batista Pereira D; Lacerda M
Lancet Glob Health; 2024 Mar; 12(3):e467-e477. PubMed ID: 38365417
[TBL] [Abstract][Full Text] [Related]
31. Implementation of G6PD testing and primaquine for
Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C
WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064
[TBL] [Abstract][Full Text] [Related]
32. Cost-Effectiveness Analysis of Sex-Stratified
Devine A; Howes RE; Price DJ; Moore KA; Ley B; Simpson JA; Dittrich S; Price RN
Am J Trop Med Hyg; 2020 Jul; 103(1):394-403. PubMed ID: 32372747
[TBL] [Abstract][Full Text] [Related]
33. Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis.
Pfeffer DA; Ley B; Howes RE; Adu P; Alam MS; Bansil P; Boum Y; Brito M; Charoenkwan P; Clements A; Cui L; Deng Z; Egesie OJ; Espino FE; von Fricken ME; Hamid MMA; He Y; Henriques G; Khan WA; Khim N; Kim S; Lacerda M; Lon C; Mekuria AH; Menard D; Monteiro W; Nosten F; Oo NN; Pal S; Palasuwan D; Parikh S; Pitaloka Pasaribu A; Poespoprodjo JR; Price DJ; Roca-Feltrer A; Roh ME; Saunders DL; Spring MD; Sutanto I; Thriemer K; Weppelmann TA; von Seidlein L; Satyagraha AW; Bancone G; Domingo GJ; Price RN
PLoS Med; 2020 May; 17(5):e1003084. PubMed ID: 32407380
[TBL] [Abstract][Full Text] [Related]
34. Glucose-6-phosphate dehydrogenase deficiency among Yemeni children residing in malaria-endemic areas of Hodeidah governorate and evaluation of a rapid diagnostic test for its detection.
Abdul-Ghani R; Mahdy MA; Saif-Ali R; Alkubati SA; Alqubaty AR; Al-Mikhlafy AA; Al-Eryani SM; Al-Mekhlafi AM; Alhaj A
Malar J; 2016 Jun; 15():327. PubMed ID: 27329471
[TBL] [Abstract][Full Text] [Related]
35. Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency.
Liu H; Zeng W; Malla P; Wang C; Lakshmi S; Kim K; Menezes L; Yang Z; Cui L
Infection; 2023 Feb; 51(1):213-222. PubMed ID: 35976559
[TBL] [Abstract][Full Text] [Related]
36. Vivax malaria in pregnancy and lactation: a long way to health equity.
Brummaier T; Gilder ME; Gornsawun G; Chu CS; Bancone G; Pimanpanarak M; Chotivanich K; Nosten F; McGready R
Malar J; 2020 Jan; 19(1):40. PubMed ID: 31969155
[TBL] [Abstract][Full Text] [Related]
37. Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency.
Baird JK
BMC Med; 2015 Dec; 13():296. PubMed ID: 26652887
[TBL] [Abstract][Full Text] [Related]
38. Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects.
Osorio L; Carter N; Arthur P; Bancone G; Gopalan S; Gupta SK; Noedl H; Kochar SK; Kochar DK; Krudsood S; Lacerda MV; Llanos-Cuentas A; Rueangweerayut R; Srinivasan R; Treiber M; Möhrle JJ; Green J
Am J Trop Med Hyg; 2015 Jan; 92(1):22-27. PubMed ID: 25385861
[TBL] [Abstract][Full Text] [Related]
39. Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities.
Domingo GJ; Advani N; Satyagraha AW; Sibley CH; Rowley E; Kalnoky M; Cohen J; Parker M; Kelley M
Int Health; 2019 Jan; 11(1):7-14. PubMed ID: 30184203
[TBL] [Abstract][Full Text] [Related]
40. Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.
Henriques G; Phommasone K; Tripura R; Peto TJ; Raut S; Snethlage C; Sambo I; Sanann N; Nguon C; Adhikari B; Pongvongsa T; Imwong M; von Seidlein L; Day NP; White NJ; Dondorp AM; Newton P; Ley B; Mayxay M
Malar J; 2018 Jun; 17(1):243. PubMed ID: 29929514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
